Fidelity Investments
DWTX

Fidelity Investments’s Dogwood Therapeutics DWTX Stock Holding History

Fidelity Investments’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-225
Closed -$1.13K – 5537
2025
Q1 		$1.13K Buy
+225
New +$1.52K ﹤0.01% 4950

Other funds holding DWTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Fidelity Investments's DWTX Position: Q2 2025 in Review

Fidelity Investments sold out of Dogwood Therapeutics (DWTX) in Q2 2025, closing a stake of 225 shares — an estimated $1.13K sold.

Fidelity Investments first reported a position in DWTX in Q1 2025 and held it in 1 quarter. The position peaked at $1.13K in Q1 2025. 10 funds tracked by Wall St. Rank hold DWTX as of Q2 2025.

  • Fidelity Investments reported no remaining Dogwood Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 225 Dogwood Therapeutics shares in Q2 2025, an estimated $1.13K.
  • Fidelity Investments first reported a position in Dogwood Therapeutics in Q1 2025 and held it in 1 quarter.
  • Fidelity Investments's Dogwood Therapeutics position peaked at $1.13K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.